Hormonal Therapy in Women of Reproductive Age with Endometriosis: an Update

A A Gheorghisan-Galateanu, Ancuța-Augustina Gheorghișan-Gălățeanu, Gheorghisan-Galateanu AA, Gheorghiu ML, M L Gheorghiu
Acta endocrinologica (Bucharest, Romania : 2005) · 2019 · vol. 15(2) , pp. 276–281 · doi:10.4183/aeb.2019.276 · PMID:31508191 · PMC6711644 · W2969702465
article OA: green CC0 ⤵ 18 in-corpus citations
📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This review updates available and investigational hormonal therapies for women of reproductive age diagnosed with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-07, 2026-07-11 · read from full text ⓘ

This update article reviews hormonal medical therapies for endometriosis in women of reproductive age, covering drugs currently available and those under investigation. The authors summarize major classes including combined hormonal contraceptives, progestogens/progestins, gonadotropin-releasing hormone (GnRH) agonists and antagonists, aromatase inhibitors, and selective progesterone or estrogen receptor modulators, while emphasizing that endometriosis medical therapy is continuously being reevaluated. The paper is a narrative update rather than original research, and it does not provide new trial methods or a specific quantitative primary outcome. This paper is centrally about endometriosis — an updated review of hormonal therapeutic options for reproductive-age women.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Medical therapy of endometriosis is under continuous reevaluation. Hereby we updated the drugs currently available or under investigation for the hormonal treatment of endometriosis.
Full text 1,399 characters · extracted from oa-doi-fallback · click to expand
- Login - Register - Home/Current Issue - About the journal - Editorial board - Online submission - Instructions for authors - Subscriptions - Foundation Acta Endocrinologica - Archive - Contact Romanian Academy The Publishing House of the Romanian Academy ACTA ENDOCRINOLOGICA (BUC) The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List Acta Endocrinologica(Bucharest) is live in PubMed Central Journal Impact Factor - click here. This Article Services Google Scholar PubMed Acta Endocrinologica (Buc) Gheorghisan-Galateanu AA, Gheorghiu ML Hormonal Therapy in Women of Reproductive Age with Endometriosis: an Update Acta Endo (Buc) 2019, 15 (2): 276-281doi: 10.4183/aeb.2019.276 Medical therapy of endometriosis is under continuous reevaluation. Hereby we updated the drugs currently available or under investigation for the hormonal treatment of endometriosis. Keywords: Endometriosis, Combined hormonal contraceptives, Progestogens/ Progestins, Gonadotropinreleasing hormone agonist, Gonadotropin-releasing hormone antagonists, Aromatase inhibitors, Selective progesterone or estrogen receptor modulators. Correspondence: Monica Livia Gheorghiu MD, “C.I.Parhon” National Institute of Endocrinology, Neuroendocrinology, Stoica Stefan 22, Bl 17 B, sc.B, ap.80, sect.1, Bucharest, 012244, Romania, E-mail: [email protected]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (40)

Cited by (18)

Source provenance

europepmc
last seen: 2026-07-27T06:15:28.040536+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:22:35.348889+00:00
License: CC0 · commercial use OK